Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Christopher J. Sayed"'
Autor:
Marília Oliveira, Kassim Rahawi, Yinghui Duan, Michael Lane, Ahmad Z. Amin, Christopher J. Sayed
Publikováno v:
Dermatology and Therapy, Vol 13, Iss 7, Pp 1577-1585 (2023)
Abstract Introduction Management of hidradenitis suppurativa (HS) often requires a combined medical/procedural approach. Biologics are frequently reserved for severe cases after irreversible tissue damage has occurred. We evaluated the association be
Externí odkaz:
https://doaj.org/article/7d3fec4ff85e4366a32f51686b9ad607
Autor:
Terri Shih, BS, Katrina Lee, MD, Maria Aleshin, MD, Richard Bennett, MD, Tiffany Mayo, MD, Ginette A. Okoye, MD, Natalie Villa, MD, Christopher J. Sayed, MD, Vivian Y. Shi, MD, Jennifer L. Hsiao, MD
Publikováno v:
JAAD International, Vol 11, Iss , Pp 117-120 (2023)
Externí odkaz:
https://doaj.org/article/fbbd9d96bdec4c3fa8d8b51db8378453
Autor:
Johannes M. Freudenberg, Zhi Liu, Jennifer Singh, Elizabeth Thomas, Christopher Traini, Deepak K. Rajpal, Christopher J. Sayed
Publikováno v:
PLoS ONE, Vol 18, Iss 4 (2023)
Hidradenitis suppurativa (HS) is a common, debilitating inflammatory skin disease linked to immune dysregulation and abnormalities in follicular structure and function. Several studies have characterized the transcriptomic profile of affected and una
Externí odkaz:
https://doaj.org/article/c8fc4c02ca044620b28d3d90290c8b14
Autor:
Rahul Masson, BS, Terri Shih, BS, Devea R. De, BS, Sarah Park, BS, Ram Parvataneni, MD, Aaron Goldberg, MD, Christopher J. Sayed, MD, Vivian Y. Shi, MD, Jennifer L. Hsiao, MD
Publikováno v:
International Journal of Women's Dermatology, Vol 8, Iss 4, p e064 (2022)
Externí odkaz:
https://doaj.org/article/ff66377631824054ae04c61a771efc6a
Publikováno v:
JAAD Case Reports, Vol 4, Iss 4, Pp 346-348 (2018)
Externí odkaz:
https://doaj.org/article/02b41808f35b4410b047f87e557a8b63
Autor:
Damon Willems, Eva-Lotta Hinzpeter, Hessel H. Van der Zee, Christopher J. Sayed, John R. Ingram, Charlotte Beaudart, Silvia M. A. A. Evers, Mickael Hiligsmann
Publikováno v:
Patient, 16(2), 153-164. Springer Science+Business Media
The Patient: patient-centered outcomes research, 16, 153-164. Adis International Ltd
The Patient: patient-centered outcomes research, 16, 153-164. Adis International Ltd
Background and Objective: Hidradenitis suppurativa is a chronic inflammatory skin disease that can lead to a substantial reduction in quality of life. Recent studies revealed high levels of unmet care needs of patients with hidradenitis suppurativa,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7346ba656316af92f74ea0bf36e4cc1
https://pure.eur.nl/en/publications/4674049a-08ac-4fa7-9c0d-3a62bfebb942
https://pure.eur.nl/en/publications/4674049a-08ac-4fa7-9c0d-3a62bfebb942
Autor:
Katherine Falloon, Benjamin Cohen, Ashwin N. Ananthakrishnan, Edward L. Barnes, Abhik Bhattacharya, Jean‐Frederic Colombel, Raymond K. Cross, Marcia S. Driscoll, Anthony P. Fernandez, Christina Ha, Hans Herfarth, Sara Horst, Jason Hou, M. Elaine Husni, Daniela Kroshinsky, Kristine A. Kuhn, Careen Y. Lowder, George Martin, Deep Parikh, Christopher J. Sayed, Lisa Schocket, Bernadette C. Siaton, Priyanka Vedak, Michael H. Weisman, Florian Rieder
Publikováno v:
Aliment Pharmacol Ther
BACKGROUND AND AIMS: Extra-intestinal manifestations (EIMs) are a common complication of inflammatory bowel diseases (IBD), affecting up to half of the patients. Despite their high prevalence, information on standardised definitions, diagnostic strat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4948f358cfded4064d76445f1e647291
https://doi.org/10.1111/apt.16853
https://doi.org/10.1111/apt.16853
Autor:
Jonathan W. Rick, Devea R. De, Terri Shih, Afsaneh Alavi, Joslyn S. Kirby, Haley B. Naik, John W. Frew, Christopher J. Sayed, Jennifer L. Hsiao, Vivian Y. Shi
Publikováno v:
Skin Appendage Disorders. 8:287-290
Introduction: Hidradenitis suppurativa (HS) patients may be at increased risk of COVID-19 infection and complications from their medications and comorbidities. There is a lack of expert consensus on recommendations for the COVID-19 vaccine for HS pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90fab496ec4e1e753c3b9b2a3a7a28c6
https://doi.org/10.1159/000521268
https://doi.org/10.1159/000521268
Autor:
Thrasivoulos Tzellos, Kelsey R. van Straalen, Athanassios Kyrgidis, Afsaneh Alavi, Noah Goldfarb, Wayne Gulliver, Gregor B. E. Jemec, Michelle A. Lowes, Angelo Valerio Marzano, Errol P. Prens, Christopher J. Sayed, Hessel H. van der Zee, Christos C. Zouboulis
Publikováno v:
Journal of the European Academy of Dermatology and Venereology, 37(2), 395-401. Wiley-Blackwell
Tzellos, T, van Straalen, K R, Kyrgidis, A, Alavi, A, Goldfarb, N, Gulliver, W, Jemec, G B E, Lowes, M A, Marzano, A V, Prens, E P, Sayed, C J, van der Zee, H H & Zouboulis, C C 2023, ' Development and validation of IHS4-55, an IHS4 dichotomous outcome to assess treatment effect for hidradenitis suppurativa ', Journal of the European Academy of Dermatology and Venereology, vol. 37, no. 2, pp. 395-401 . https://doi.org/10.1111/jdv.18632
Tzellos, T, van Straalen, K R, Kyrgidis, A, Alavi, A, Goldfarb, N, Gulliver, W, Jemec, G B E, Lowes, M A, Marzano, A V, Prens, E P, Sayed, C J, van der Zee, H H & Zouboulis, C C 2023, ' Development and validation of IHS4-55, an IHS4 dichotomous outcome to assess treatment effect for hidradenitis suppurativa ', Journal of the European Academy of Dermatology and Venereology, vol. 37, no. 2, pp. 395-401 . https://doi.org/10.1111/jdv.18632
Background: Validated, inclusive and easy-to-use outcomes for hidradenitis suppurativa are essential both in the clinical trial setting and clinical practice. The continuous IHS4 is a validated tool that dynamically assesses nodules/abscesses/drainin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e1a8f33df6b7c9a7a2eaa276267abf7
https://pure.eur.nl/en/publications/2062a880-3b37-4d25-b4cf-fb60f2805927
https://pure.eur.nl/en/publications/2062a880-3b37-4d25-b4cf-fb60f2805927
Autor:
Kelsey R. van Straalen, Thrasyvoulos Tzellos, Afsaneh Alavi, Farida Benhadou, Carlos Cuenca-Barrales, Mathilde Daxhelet, Mathieu Daoud, Ourania Efthymiou, Evangelos J. Giamarellos-Bourboulis, Philippe Guillem, Wayne Gulliver, Gregor Borut Ernst Jemec, Alexandros Katoulis, Anke Koenig, Elizabeth Lazaridou, Michelle A. Lowes, Angelo V. Marzano, Łukasz Matusiak, Alejandro Molina-Leyva, Chiara Moltrasio, Andreas Pinter, Concetta Potenza, Errol P. Prens, Jorge Romaní, Ditte Marie L. Saunte, Christopher J Sayed, Nevena Skroza, Dimitra Stergianou, Jacek C. Szepietowski, Anastasia Trigoni, Eva Vilarrasa, Athanassios Kyrgidis, Christos C. Zouboulis, Hessel H. van der Zee
Publikováno v:
Dermatology.
Background: Previously, a new dichotomous outcome was developed, calculated as 55% reduction in the International Hidradenitis Suppurativa 4 score (IHS4-55). It was validated in datasets of adalimumab and placebo treated HS patients. External validat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e18956c603850387d57e9aa1766b9677
https://doi.org/10.1159/000528968
https://doi.org/10.1159/000528968